Alpha-1 anti-trypsin deficiency

2 trials 2 recruiting MedDRA PT
2 Registered trials
2 Recruiting
1 Unique sponsors
1 Unique IMPs
2 Commercial trials
Drug classes (ATC)
— ATC code not specified 2
Mechanism of action (INN-stem analysis)
siRNA 1 substance
Phase III: 2

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase III

2 trials
  • Takeda Development Center Americas Inc. Commercial
    FAZIRSIRAN
    2022-501943-34-00 13 countries 2023 n=103 Orphan
    Recruiting
  • Takeda Development Center Americas Inc. Commercial
    FAZIRSIRAN
    2023-503497-21-00 3 countries 2023 n=15 Orphan
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Takeda Development Center Americas Inc. Commercial 2 Phase III 2
New trials by year
2023
2
← All indication landscapes